Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity.
暂无分享,去创建一个
[1] J. Hayashi,et al. Human mitochondria and mitochondrial genome function as a single dynamic cellular unit , 1994, The Journal of cell biology.
[2] M. Bennett. The Laboratory Diagnosis of Inborn Errors of Mitochondrial Fatty Acid Oxidation , 1990, Annals of clinical biochemistry.
[3] H. Nau,et al. Valproate (VPA) Metabolites in Various Clinical Conditions of Probable VPA‐Associated Hepatotoxicity , 1993, Epilepsia.
[4] C. S. Chen,et al. Purification and characterization of novel "2-arylpropionyl-CoA epimerases" from rat liver cytosol and mitochondria. , 1993, The Journal of biological chemistry.
[5] K. Ishak,et al. Amiodarone hepatotoxicity: Prevalence and clinicopathologic correlations among 104 patients , 1989, Hepatology.
[6] D. Pessayre,et al. Evaluation of human blood lymphocytes as a model to study the effects of drugs on human mitochondria. Effects of low concentrations of amiodarone on fatty acid oxidation, ATP levels and cell survival. , 1993, Biochemical pharmacology.
[7] R. Peters,et al. Tetracycline-induced fatty liver in nonpregnant patients. A report of six cases. , 1967, American journal of surgery.
[8] K Farrell,et al. Identification and characterization of the glutathione and N-acetylcysteine conjugates of (E)-2-propyl-2,4-pentadienoic acid, a toxic metabolite of valproic acid, in rats and humans. , 1991, Drug metabolism and disposition: the biological fate of chemicals.
[9] P. Remington,et al. Decreasing trends in Reye syndrome and aspirin use in Michigan, 1979 to 1984. , 1986, Pediatrics.
[10] S. Shanske. Mitochondrial Encephalomyopathies: Defects of Nuclear DNA , 1992, Brain pathology.
[11] W. S. Thayer,et al. Comparative effects of chronic ethanol consumption on the properties of mitochondria from rat brain and liver. , 1992, Alcoholism, clinical and experimental research.
[12] L. Journey,et al. The effect of terramycin on the fine structure of HeLa cell mitochondria. , 1963, Cancer research.
[13] S. Kolvraa,et al. Frequency of the G985 MCAD mutation in the general population , 1991, The Lancet.
[14] B. Robson,et al. Biochemical effects of the hypoglycaemic compound pent--4-enoic acid and related non-hypoglycaemic fatty acids. , 1968, The Biochemical journal.
[15] Y. Hatefi. The mitochondrial electron transport and oxidative phosphorylation system. , 1985, Annual review of biochemistry.
[16] D. Larrey,et al. Microvesicular steatosis after ketoprofen administration , 1991 .
[17] D. Pessayre,et al. Dual effect of amiodarone on mitochondrial respiration. Initial protonophoric uncoupling effect followed by inhibition of the respiratory chain at the levels of complex I and complex II. , 1990, The Journal of pharmacology and experimental therapeutics.
[18] S. Passi,et al. Antimitochondrial effect of saturated medium chain length (C8-C13) dicarboxylic acids. , 1984, Biochemical pharmacology.
[19] S. Krähenbühl,et al. Stereological and functional analysis of liver mitochondria from rats with secondary biliary cirrhosis: Impaired mitochondrial metabolism and increased mitochondrial content per hepatocyte , 1992, Hepatology.
[20] Charles A. Stanley. Disorders of Fatty Acid Oxidation , 1995 .
[21] C. Lieber,et al. Difference in hepatic metabolism of long- and medium-chain fatty acids: the role of fatty acid chain length in the production of the alcoholic fatty liver. , 1967, The Journal of clinical investigation.
[22] G. Labbe,et al. Polymorphism of dextromethorphan oxidation in a French population. , 1987, British journal of clinical pharmacology.
[23] T. Hashimoto,et al. Identification of Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency in Three Patients Previously Diagnosed with Long-Chain Acyl-CoA Dehydrogenase Deficiency , 1993, Pediatric Research.
[24] G. Azzone,et al. Uncoupling of oxidative phosphorylation. 2. Alternative mechanisms: intrinsic uncoupling or decoupling? , 1987, Biochemistry.
[25] R. Dickinson,et al. Studies on the reactivity of acyl glucuronides--IV. Covalent binding of diflunisal to tissues of the rat. , 1993, Biochemical pharmacology.
[26] D. D. Vivo. Reye syndrome: A metabolic response to an acute mitochondrial insult , 1978 .
[27] C. Degott,et al. Microvesicular steatosis of the liver. , 1990, Acta clinica Belgica.
[28] Suga Tetsuya,et al. Clofibrate-like effects of acetylsalicylic acid on peroxisomes and on hepatic and serum triglyceride levels. , 1979 .
[29] E. Bertini,et al. Fatal infantile liver failure associated with mitochondrial DNA depletion. , 1992, The Journal of pediatrics.
[30] C. Estler,et al. Role of sex and age in the tetracycline-induced hepatic steatosis. I. Comparative study on the effect of rolitetracycline on some parameters of hepatic lipid metabolism in male and female mice. , 1980, Toxicology and applied pharmacology.
[31] H. Osmundsen,et al. On the mechanisms of some pharmacological actions of the hypoglycaemic toxins hypoglycin and pent-4-enoic acid. A way out of the present confusion. , 1976, Biochemical pharmacology.
[32] M. Whitehouse,et al. INHIBITION OF ELECTRON TRANSPORT AND COUPLED PHOSPHORYLATION IN LIVER MITOCHONDRIA BY CHOLANIC (BILE) ACIDS AND THEIR CONJUGATES. , 1965, Biochimica et biophysica acta.
[33] J. Morita,et al. Hypocarnitinemia in the Handicapped Individuals who Receive a Polypharmacy of Antiepileptic Drugs , 1986, Neuropediatrics.
[34] M. Kaplan. Current concepts: acute fatty liver of pregnancy , 1985 .
[35] K. Schrör,et al. Equipotent inhibition by R(-)-, S(+)- and racemic ibuprofen of human polymorphonuclear cell function in vitro. , 1993, British journal of clinical pharmacology.
[36] S. Sherlock,et al. Impaired oxidation of debrisoquine in patients with perhexiline liver injury. , 1984, Gut.
[37] D. Pessayre,et al. Increased ethane exhalation, an in vivo index of lipid peroxidation, in alcohol-abusers. , 1993, Gut.
[38] C. Roe,et al. Identification of a common mutation in patients with medium-chain acyl-CoA dehydrogenase deficiency. , 1990, Biochemical and biophysical research communications.
[39] W. Coleman,et al. Ethanol-elicited alterations in the oligomycin sensitivity and structural stability of the mitochondrial F0 . F1 ATPase. , 1987, The Journal of biological chemistry.
[40] P. Pinsky,et al. Public Health Service study of Reye's syndrome and medications. Report of the main study. , 1987, JAMA.
[41] T. Baillie,et al. Cytochrome P-450--catalyzed formation of delta 4-VPA, a toxic metabolite of valproic acid. , 1987, Science.
[42] D. Harrison,et al. Pathology of alcoholic liver disease. , 1993, Bailliere's clinical gastroenterology.
[43] C. T. Kunelis,et al. FATTY LIVER OF PREGNANCY AND ITS RELATIONSHIP TO TETRACYCLINE THERAPY. , 1965, The American journal of medicine.
[44] A. Cederbaum,et al. Effects of chronic ethanol treatment of mitochondrial functions damage to coupling site I. , 1974, Archives of biochemistry and biophysics.
[45] D. Millington,et al. Formation of a free acyl adenylate during the activation of 2-propylpentanoic acid. Valproyl-AMP: a novel cellular metabolite of valproic acid. , 1992, The Journal of biological chemistry.
[46] K. Tanaka,et al. Intramitochondrial folding and assembly of medium-chain acyl-CoA dehydrogenase (MCAD). Demonstration of impaired transfer of K304E-variant MCAD from its complex with hsp60 to the native tetramer. , 1994, Journal of Biological Chemistry.
[47] M. V. Marsh,et al. Interrelationships between xenobiotic metabolism and lipid biosynthesis. , 1983, Biochemical pharmacology.
[48] Y. Antonenko,et al. Selective effect of inhibitors on inner mitochondrial membrane channels , 1991, FEBS letters.
[49] J. Byczkowski,et al. Inhibition of state 3 respiration and prostaglandin beta-oxidation in rat liver mitochondria treated with some neurotropic and anti-pyretic drugs. , 1978, General pharmacology.
[50] H. Sheehan. The Pathology of Acute Yellow Atrophy and Delayed Chloroform Poisoning , 1940 .
[51] R. Day,et al. Stereoselective disposition of ibuprofen enantiomers in infants. , 1985 .
[52] G. Labbe,et al. Metabolic activation of the antidepressant tianeptine. II. In vivo covalent binding and toxicological studies at sublethal doses. , 1989, Biochemical Pharmacology.
[53] W. Coleman,et al. Effect of chronic ethanol consumption on hepatic mitochondrial transcription and translation. , 1991, Biochimica et biophysica acta.
[54] G. Azzone,et al. Uncoupling of oxidative phosphorylation. 1. Protonophoric effects account only partially for uncoupling. , 1987, Biochemistry.
[55] D. Wallace,et al. Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease. , 1992, Mutation research.
[56] B. Corkey,et al. Assay of citric acid cycle intermediates and related compounds--update with tissue metabolite levels and intracellular distribution. , 1979, Methods in enzymology.
[57] V. Maddaiah. Ammonium inhibition of fatty acid oxidation in rat liver mitochondria. A possible cause of fatty liver in Reye's syndrome and urea cycle defects. , 1985, Biochemical and biophysical research communications.
[58] C. Lee,et al. Reye's syndrome: mitochondrial swelling and Ca2+ release induced by Reye's plasma, allantoin, and salicylate. , 1986, Archives of biochemistry and biophysics.
[59] D. Pessayre,et al. Metabolic activation of the new tricyclic antidepressant tianeptine by human liver cytochrome P450. , 1990, Biochemical pharmacology.
[60] V. Tiranti,et al. Maternally inherited myopathy and cardiomyopathy: association with mutation in mitochondrial DNA tRNALeu(UUR) , 1991, The Lancet.
[61] P. Corr,et al. Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation. , 1989, The Journal of clinical investigation.
[62] D. Gozal,et al. Prevalence of medium-chain acyl-coenzyme A dehydrogenase deficiency in the sudden infant death syndrome. , 1993, The Journal of pediatrics.
[63] E. A. Kean. Selective inhibition of acyl-CoA dehydrogenases by a metabolite of hypoglycin. , 1976, Biochimica et biophysica acta.
[64] N. Kaplowitz,et al. Impaired uptake of glutathione by hepatic mitochondria from chronic ethanol-fed rats. Tracer kinetic studies in vitro and in vivo and susceptibility to oxidant stress. , 1991, The Journal of clinical investigation.
[65] B. Amendt,et al. Short-chain acyl-coenzyme A dehydrogenase deficiency. Clinical and biochemical studies in two patients. , 1987, The Journal of clinical investigation.
[66] N. Gregersen,et al. The frequency of a disease‐causing point mutation in the gene coding for medium‐chain acyl‐CoA dehydrogenase in sudden infant death syndrome , 1993, Acta paediatrica.
[67] D. N. Williams,et al. Zidovudine-associated myopathy. , 1989, The American journal of medicine.
[68] W. Fiers,et al. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. , 1992, The Journal of biological chemistry.
[69] C. Münscher,et al. Human aging is associated with various point mutations in tRNA genes of mitochondrial DNA. , 1993, Biological chemistry Hoppe-Seyler.
[70] J. H. Williams,et al. In vitro Action of Aureomycin on Oxidative Phosphorylation in Animal Tissues , 1952, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[71] C. Stanley,et al. Medium‐chain and long‐chain acyl CoA dehydrogenase deficiency: Clinical, pathologic and ultrastructural differentiation from Reye's syndrome , 1986, Hepatology.
[72] A. Cederbaum,et al. The effect of chronic ethanol consumption on NADH- and NADPH-dependent generation of reactive oxygen intermediates by isolated rat liver nuclei. , 1992, Alcohol and alcoholism.
[73] W. S. Thayer,et al. Effects of chronic ethanol intoxication on oxidative phosphorylation in rat liver submitochondrial particles. , 1979, The Journal of biological chemistry.
[74] C. Lieber,et al. Decreased cytochrome oxidase activity in hepatic mitochondria after chronic ethanol consumption and the possible role of decreased cytochrome aa3 content and changes in phospholipids. , 1984, Biochimica et biophysica acta.
[75] P. Coates,et al. Molecular basis of mitochondrial fatty acid oxidation defects. , 1992, Journal of lipid research.
[76] J. Ribalta,et al. Acute fatty liver of pregnancy: a clinical study of 12 episodes in 11 patients. , 1994, Gut.
[77] R. Kaslow,et al. Public Health Service study on Reye's syndrome and medications. Report of the pilot phase. , 1985, The New England journal of medicine.
[78] C. Marescaux,et al. Sodium valproate-induced hyperammonemia in the rat: role of the kidney. , 1983, European journal of pharmacology.
[79] F. Suchy,et al. Acute hepatic failure associated with the use of sodium valproate. , 1979, The New England journal of medicine.
[80] W. Fiers,et al. Molecular mechanisms of tumor necrosis factor‐induced cytotoxicity , 1994, FEBS letters.
[81] P. Gele,et al. The metabolic pathways of tianeptine, a new antidepressant, in healthy volunteers. , 1990, Drug metabolism and disposition: the biological fate of chemicals.
[82] F. Endo,et al. Carnitine deficiency and hyperammonemia associated with valproic acid therapy. , 1982, The Journal of pediatrics.
[83] A. Yasuhara,et al. Reye-like syndrome associated with valproic acid , 1983, Brain and Development.
[84] J. Ruysschaert,et al. Amiodarone induced modifications of the phospholipid physical state. A fluorescence polarization study. , 1986, Biochemical pharmacology.
[85] P. Groot,et al. Fatty acid activation: specificity, localization, and function. , 1976, Advances in lipid research.
[86] E. Eichner. The hematologic disorders of alcoholism. , 1973, The American journal of medicine.
[87] G. Getz,et al. Induction of (omega-1)-oxidation of monocarboxylic acids by acetylsalicylic acid. , 1993, Journal of lipid research.
[88] M. Beaugrand,et al. [Hepatitis due to perhexiline maleate. Development of cirrhosis after interruption of the drug. Report of two cases (author's transl)]. , 1977, Gastroenterologie clinique et biologique.
[89] S. Shaw,et al. Lipid peroxidation, iron mobilization and radical generation induced by alcohol. , 1989, Free radical biology & medicine.
[90] H. Dowling,et al. Effect of large doses of aureomycin on human liver. , 1951, A.M.A. archives of internal medicine.
[91] L. Lewis,et al. Ultrastructural changes associated with reduced mitochondrial DNA and impaired mitochondrial function in the presence of 2'3'-dideoxycytidine , 1992, Antimicrobial Agents and Chemotherapy.
[92] J. Lou,et al. Suppression of mitochondrial mRNA levels and mitochondrial function in cells responding to the anticellular action of interferon. , 1994, Journal of interferon research.
[93] G. Millward-Sadler,et al. ACUTE LIVER DISEASE ASSOCIATED WITH SODIUM VALPROATE , 1980, The Lancet.
[94] J. Tredger,et al. Hepatotoxicity to sodium valproate: a review. , 1984, Gut.
[95] K. Geisinger,et al. Reye's syndrome in adults. A case report and review of the literature. , 1986, Archives of internal medicine.
[96] M. Menten,et al. SALICYLATE POISONING: REPORT OF FOUR CASES , 1945 .
[97] D. Hale,et al. Fatty acid oxidation disorders: a new class of metabolic diseases. , 1992, The Journal of pediatrics.
[98] C. Lieber,et al. Biochemical and Morphological Alterations of Baboon Hepatic Mitochondria After Chronic Ethanol Consumption , 1984, Hepatology.
[99] G. Grimber,et al. Letter to the Editor: A Mechanism for Valproate-Induced Hyperammonemia , 1981, Pediatric Research.
[100] A. CrastesdePaulet. Free radicals and aging , 1990 .
[101] G. Granneman,et al. The Hepatotoxicity of Valproic Acid and Its Metabolites in Rats. I. Toxicologic, Biochemical and Histopathologic Studies , 1984, Hepatology.
[102] L. Schonberger,et al. Changing epidemiology of Reye syndrome in the United States. , 1986, Pediatrics.
[103] K. K. Lai,et al. Fulminant hepatic failure associated with 2',3'-dideoxyinosine (ddI). , 1991, Annals of internal medicine.
[104] G. Labbe,et al. Metabolic activation of the antidepressant tianeptine. I. Cytochrome P-450-mediated in vitro covalent binding. , 1989, Biochemical pharmacology.
[105] W. Dodson,et al. Chronic valproate administration reduces fasting ketonemia in children , 1983, Neurology.
[106] G. Fenichel,et al. Valproate hepatotoxicity: two new cases, a summary of others, and recommendations. , 1985, Pediatric neurology.
[107] C. Lieber. Alcohol and the liver: 1994 update. , 1994, Gastroenterology.
[108] W. Hauswirth,et al. A method for assessing damage to mitochondrial DNA caused by radiation and epichlorohydrin. , 1985, Molecular Pharmacology.
[109] R. Peters,et al. Alcoholic foamy degeneration ― a pattern of acute alcoholic injury of the liver , 1983 .
[110] F. Zannad,et al. [Acute hepatitis attributed to amiodarone]. , 1986, Gastroentérologie Clinique et Biologique.
[111] G. Getz,et al. Effect of Reye's syndrome serum on isolated chinchilla liver mitochondria. , 1985, The Journal of clinical investigation.
[112] R. A. Nakashima,et al. Studies on the mechanism of uncoupling by amine local anesthetics. Evidence for mitochondrial proton transport mediated by lipophilic ion pairs. , 1983, The Journal of biological chemistry.
[113] P. D. de Jong,et al. Base substitutions, frameshifts, and small deletions constitute ionizing radiation-induced point mutations in mammalian cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[114] C. Münscher,et al. The point mutation of mitochondrial DNA characteristic for MERRF disease is found also in healthy people of different ages , 1993, FEBS letters.
[115] E H KAPLAN,et al. Effects of salicylate and other benzoates on oxidative enzymes of the tricarboxylic acid cycle in rat tissue homogenates. , 1954, Archives of biochemistry and biophysics.
[116] A. J. Mcadams,et al. A Comparison of Liver Ultrastructure in Salicylate Intoxication and Reye's Syndrome , 1984, Hepatology.
[117] K. Tanaka,et al. Mutations in the medium chain acyl‐CoA dehydrogenase (MCAD) gene , 1992, Human mutation.
[118] N. Arnheim,et al. Deleterious mitochondrial DNA mutations accumulate in aging human tissues. , 1992, Mutation research.
[119] D. Danks,et al. Prevalence of K329E mutation in medium-chain acyl-CoA dehydrogenase gene determined from Guthrie cards , 1991, The Lancet.
[120] K. Veitch,et al. Valproate and mitochondria. , 1993, Biochemical pharmacology.
[121] D. Turnbull,et al. Valproate causes metabolic disturbance in normal man. , 1986, Journal of neurology, neurosurgery, and psychiatry.
[122] J. Miquel,et al. Oxygen-induced mitochondrial damage and aging. , 1992, EXS.
[123] R. Insel,et al. Frequency of Medium-Chain Acyl-CoA Dehydrogenase Deficiency G-985 Mutation in Sudden Infant Death Syndrome , 1992, Pediatric Research.
[124] J. Caballería,et al. Alcoholic foamy degeneration in Spain. Prevalence and clinico-pathological features. , 2008, Liver.
[125] G. Finocchiaro,et al. The enzymatic basis for the metabolism and inhibitory effects of valproic acid: dehydrogenation of valproyl-CoA by 2-methyl-branched-chain acyl-CoA dehydrogenase. , 1990, Biochimica et biophysica acta.
[126] P. Humphreys,et al. Valproic Acid Producing a Reye-Like Syndrome , 1982, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[127] K. Tanaka,et al. Impaired tetramer assembly of variant medium-chain acyl-coenzyme A dehydrogenase with a glutamate or aspartate substitution for lysine 304 causing instability of the protein. , 1992, The Journal of biological chemistry.
[128] J. López-Novoa,et al. Effect of valproate infusion in vivo on renal metabolism in fasted rats. , 1989, Biochemical pharmacology.
[129] A. Kroon,et al. On the effect of chloramphenicol and oxytetracycline on the biogenesis of mammalian mitochondria. , 1970, Biochimica et biophysica acta.
[130] H. Schulz,et al. Beta oxidation of fatty acids. , 1991, Biochimica et biophysica acta.
[131] O. Koch,et al. Biochemical lesions of liver mitochondria from rats after chronic alcohol consumption. , 1977, Experimental and molecular pathology.
[132] J. Gabrilove,et al. Tumor necrosis factor and the acute metabolic response to tissue injury in man. , 1988 .
[133] U. Kodavanti,et al. Cationic amphiphilic drugs and phospholipid storage disorder. , 1990, Pharmacological reviews.
[134] D. Wallace,et al. Hypoxemia is associated with mitochondrial DNA damage and gene induction. Implications for cardiac disease. , 1991, JAMA.
[135] K. Kamath,et al. Augmented tumour necrosis factor in Reye's syndrome associated with dengue virus , 1992, The Lancet.
[136] A. Cederbaum,et al. Increased production of reactive oxygen species by rat liver mitochondria after chronic ethanol treatment. , 1994, Archives of biochemistry and biophysics.
[137] M. Schaefer,et al. Cellular accumulation of amiodarone and desethylamiodarone in cultured human cells. Consequences of drug accumulation on cellular lipid metabolism and plasma membrane properties of chronically exposed cells. , 1993, Biochemical pharmacology.
[138] M. Roberfroid,et al. Investigation into the mechanism of tetracycline-induced steatosis: study in isolated hepatocytes. , 1989, Toxicology and applied pharmacology.
[139] F. Iglicki,et al. Genetically determined oxidation polymorphism and drug hepatotoxicity. Study of 51 patients. , 1989, Journal of hepatology.
[140] J. Tonsgard. Serum dicarboxylic acids in patients with Reye syndrome. , 1986, The Journal of pediatrics.
[141] C. Lee,et al. Reye's syndrome: salicylates and mitochondrial functions. , 1984, Biochemical pharmacology.
[142] J. Leonard,et al. SODIUM VALPROATE AND ORNITHINE CARBAMYL TRANSFERASE DEFICIENCY , 1981, The Lancet.
[143] J. Glasgow,et al. Reye's syndrome 30 years on. , 1993, BMJ.
[144] N. Kaplowitz,et al. Effect of chronic ethanol feeding on glutathione and functional integrity of mitochondria in periportal and perivenous rat hepatocytes. , 1994, The Journal of clinical investigation.
[145] A. Burette,et al. Acute hepatic injury associated with minocycline. , 1984, Archives of internal medicine.
[146] S. Kolvraa,et al. Three RFLPs defining a haplotype associated with the common mutation in human medium-chain acyl-CoA dehydrogenase (MCAD) deficiency occur in Alu repeats. , 1993, American journal of human genetics.
[147] C. Stanley,et al. Relationship between unusual hepatic acyl coenzyme A profiles and the pathogenesis of Reye syndrome. , 1988, The Journal of clinical investigation.
[148] S. Pande. On rate-controlling factors of long chain fatty acid oxidation. , 1971, The Journal of biological chemistry.
[149] T. Hashimoto,et al. Induction of peroxisomal beta-oxidation by the administration of acetylsalicylic acid. , 1981, Toxicology and applied pharmacology.
[150] J. Tocanne,et al. Interactions of amiodarone with model membranes and amiodarone-photoinduced peroxidation of lipids. , 1992, Biochemical pharmacology.
[151] F. Dreifuss. FATAL LIVER FAILURE IN CHILDREN ON VALPROATE , 1987, The Lancet.
[152] G. Grimber,et al. Inhibition of ureagenesis by valproate in rat hepatocytes. Role of N-acetylglutamate and acetyl-CoA. , 1983, The Biochemical journal.
[153] F. Mullick,et al. HEPATIC AND CEREBRAL PATHOLOGY FINDINGS IN CHILDREN WITH FATAL SALICYLATE INTOXICATION: FURTHER EVIDENCE FOR A CAUSAL RELATION BETWEEN SALICYLATE AND REYE'S SYNDROME , 1983, The Lancet.
[154] R. Mitchell,et al. Comparison of Cytosolic and Mitochondrial Hepatic Enzyme Alterations in Reye's Syndrome , 1980, Pediatric Research.
[155] S. Kolvraa,et al. Non-ketotic C6-C10-dicarboxylic aciduria: biochemical investigations of two cases. , 1980, Clinica chimica acta; international journal of clinical chemistry.
[156] J. Ontko,et al. Increased secretion of very low density lipoprotein triglyceride following inhibition of long chain fatty acid oxidation in isolated rat liver. , 1981, The Journal of biological chemistry.
[157] J. Leonard,et al. Pregnancy and fetal long-chain 3-hydroxyacyl coenzyme A dehydrogenase deficiency , 1993, The Lancet.
[158] G. Labbe,et al. Amineptine, a tricyclic antidepressant, inhibits the mitochondrial oxidation of fatty acids and produces microvesicular steatosis of the liver in mice. , 1988, The Journal of pharmacology and experimental therapeutics.
[159] S. Dimauro,et al. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy , 1991, The Lancet.
[160] M. Norenberg,et al. Glutaric acidemia type II: clinical, biochemical, and morphologic considerations. , 1982, The Journal of pediatrics.
[161] F. Renger. [Progress in hepatology]. , 1968, Deutsche Zeitschrift fur Verdauungs- und Stoffwechselkrankheiten.
[162] H. Sherratt,et al. The antagonism of the toxicity of hypoglycin by glycine. , 1981, Biochemical pharmacology.
[163] B. Ames,et al. Oxidants, antioxidants, and the degenerative diseases of aging. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[164] D. Shibata,et al. A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging human tissues. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[165] J. Idle,et al. Impaired oxidation of debrisoquine in patients with perhexiline neuropathy. , 1982, British medical journal.
[166] J. Robishaw,et al. Coenzyme A metabolism. , 1985, The American journal of physiology.
[167] K. Otani,et al. Associations Between Risk Factors for Valproate Hepatotoxicity and Altered Valproate Metabolism , 1992, Epilepsia.
[168] F. Van hoof,et al. In vitro effects of eight-carbon fatty acids on oxidations in rat liver mitochondria. , 1990, Biochemical pharmacology.
[169] F. Dreifuss,et al. Valproic acid hepatic fatalities , 1987, Neurology.
[170] A. Kamoun,et al. Analysis of the side effects of tianeptine. , 1988, Clinical neuropharmacology.
[171] A. Markham,et al. The mechanism of inhibition of mitochondrial oxidative phosphorylation by the nonsteroidal anti-inflammatory agent diflunisal. , 1983, Biochemical pharmacology.
[172] K. Otani,et al. Is 2‐Propyl‐4‐Pentenoic Acid, a Hepatotoxic Metabolite of Valproate, Responsible for Valproate‐Induced Hyperammonemia? , 1992, Epilepsia.
[173] G. Labbe,et al. Effects of various tetracycline derivatives on in vitro and in vivo beta-oxidation of fatty acids, egress of triglycerides from the liver, accumulation of hepatic triglycerides, and mortality in mice. , 1991, Biochemical pharmacology.
[174] S. Sherlock,et al. Acute cholestasis, hepatic failure, and fatty liver in the alcoholic. , 1978, Scandinavian journal of gastroenterology.
[175] M. Castro‐Gago,et al. Effects of acute valproate administration on carnitine metabolism in mouse serum and tissues. , 1990, Biochemical pharmacology.
[176] J. Saudubray,et al. Inborn Metabolic Diseases: Diagnosis and Treatment , 1995 .
[177] A. Kroon,et al. Tissue distribution and effects on mitochondrial protein synthesis of tetracyclines after prolonged continuous intravenous administration to rats. , 1981, Biochemical pharmacology.
[178] N. Gerber,et al. Reye-like syndrome associated with valproic acid therapy. , 1979, The Journal of pediatrics.
[179] J. Galdabini,et al. Case 4-1981 , 1981 .
[180] J. Deeney,et al. Ca2+ responses to interleukin 1 and tumor necrosis factor in cultured human skin fibroblasts. Possible implications for Reye syndrome. , 1991, The Journal of clinical investigation.
[181] T. Baillie,et al. Cytochrome P-450-catalyzed desaturation of valproic acid in vitro. Species differences, induction effects, and mechanistic studies. , 1988, The Journal of biological chemistry.
[182] L. Britt,et al. HEPATOTOXICITY PRODUCED BY TETRACYCLINE OVERDOSAGE. , 1965, JAMA.
[183] T. Baillie,et al. Effects of polytherapy with phenytoin, carbamazepine, and stiripentol on formation of 4‐ene‐valproate, a hepatotoxic metabolite of valproic acid , 1990, Clinical pharmacology and therapeutics.
[184] H. D. du Buy,et al. Selective Localization of Tetracycline in Mitochondria of Living Cells , 1961, Science.
[185] F. Van hoof,et al. Cytochrome aa3 depletion is the cause of the deficient mitochondrial respiration induced by chronic valproate administration. , 1992, Biochemical pharmacology.
[186] R. Day,et al. The effect of the enantiomers of ibuprofen and flurbiprofen on the beta-oxidation of palmitate in the rat. , 1992, Chirality.
[187] H. Terada,et al. Uncouplers of oxidative phosphorylation. , 1990, Environmental health perspectives.
[188] L. Vallée,et al. CoA esters of valproic acid and related metabolites are oxidized in peroxisomes through a pathway distinct from peroxisomal fatty and bile acyl‐CoA β‐oxidation , 1993, FEBS letters.
[189] B. Kristal,et al. Sensitivity of mitochondrial transcription to different free radical species. , 1994, Free radical biology & medicine.
[190] J. Duszyński,et al. An appraisal of the functional significance of the inhibitory effect of long chain acyl‐CoAs on mitochondrial transports , 1974, FEBS letters.
[191] F. Sanger,et al. Sequence and organization of the human mitochondrial genome , 1981, Nature.
[192] D. Trauner,et al. Inhibition of fatty acid beta oxidation by influenza B virus and salicylic acid in mice , 1988, Neurology.
[193] S. Pande,et al. Reversible inhibition of mitochondrial adenosine diphosphate phosphorylation by long chain acyl coenzyme A esters. , 1971, The Journal of biological chemistry.
[194] E. Chapnick,et al. Zidovudine‐induced hepatitis , 1992, Journal of Internal Medicine.
[195] T. Tracy,et al. Metabolic inversion of (R)-ibuprofen. Epimerization and hydrolysis of ibuprofenyl-coenzyme A. , 1992, Drug metabolism and disposition: the biological fate of chemicals.
[196] R. Reye,et al. ENCEPHALOPATHY AND FATTY DEGENERATION OF THE VISCERA. A DISEASE ENTITY IN CHILDHOOD. , 1963, Lancet.
[197] K. Tanaka,et al. Molecular basis of medium chain acyl-coenzyme A dehydrogenase deficiency. An A to G transition at position 985 that causes a lysine-304 to glutamate substitution in the mature protein is the single prevalent mutation. , 1990, The Journal of clinical investigation.
[198] K. Tanaka,et al. Molecular survey of a prevalent mutation, 985A-to-G transition, and identification of five infrequent mutations in the medium-chain Acyl-CoA dehydrogenase (MCAD) gene in 55 patients with MCAD deficiency. , 1991, American journal of human genetics.
[199] S. Kolvraa,et al. The occurrence of C6--C10-dicarboxylic acids in urine from patients and rats treated with dipropylacetate. , 1980, Biochemical medicine.
[200] O. Lantto,et al. Studies on the ethanol-induced decrease of fatty acid oxidation in rat and human liver slices. , 1973, Life sciences.
[201] T. Baillie,et al. Metabolism of valproic acid by hepatic microsomal cytochrome P-450. , 1984, Biochemical and biophysical research communications.
[202] N. Dzimiri,et al. Actions of amiodarone on mitochondrial ATPase and lactate dehydrogenase activities in guinea pig heart preparations. , 1993, European journal of pharmacology.
[203] G. Getz,et al. Induction of omega-oxidation of monocarboxylic acids in rats by acetylsalicylic acid. , 1991, The Journal of clinical investigation.
[204] C. Pettinelli,et al. 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trial. , 1990, The New England journal of medicine.
[205] A. Martín,et al. Inhibition by valproic acid of pyruvate uptake by brain mitochondria. , 1982, Biochemical pharmacology.
[206] Carnitine Metabolism in Valproate-Treated Rats: The Effect of L-Carnitine Supplementation , 1987, Pediatric Research.
[207] F. Frerman,et al. Inhibition of general acyl CoA dehydrogenase by electron transfer flavoprotein semiquinone. , 1981, Biochemical and biophysical research communications.
[208] Robert A. Harris,et al. Influence of valproic acid on hepatic carbohydrate and lipid metabolism. , 1983, Archives of biochemistry and biophysics.
[209] S. Schenker,et al. Fatty liver induced by tetracycline in the rat. Dose-response relationships and effect of sex. , 1975, Gastroenterology.
[210] R. Hauhart,et al. Amelioration of Adverse Effects of Valproic Acid on Ketogenesis and Liver Coenzyme A Metabolism by Cotreatment with Pantothenate and Carnitine in Developing Mice: Possible Clinical Significance , 1992, Pediatric Research.
[211] T. Hennet,et al. Tumour necrosis factor-α induces superoxide anion generation in mitochondria of L929 cells , 1993 .
[212] B. Shan,et al. Interferon selectively inhibits the expression of mitochondrial genes: a novel pathway for interferon‐mediated responses. , 1990, The EMBO journal.
[213] S. Krähenbühl,et al. Reduced activity of the electron transport chain in liver mitochondria isolated from rats with secondary biliary cirrhosis , 1992, Hepatology.
[214] F. Zoulim,et al. Nucleoside analogs in the treatment of chronic viral hepatitis. Efficiency and complications. , 1994, Journal of hepatology.
[215] G. Labbe,et al. Tianeptine, a new tricyclic antidepressant metabolized by beta-oxidation of its heptanoic side chain, inhibits the mitochondrial oxidation of medium and short chain fatty acids in mice. , 1989, Biochemical pharmacology.
[216] J. Carroll,et al. A single therapeutic dose of valproate affects liver carbohydrate, fat, adenylate, amino acid, coenzyme A, and carnitine metabolism in infant mice: possible clinical significance. , 1985, Life sciences.
[217] E. Downar,et al. Amiodarone-associated phospholipidosis and fibrosis of the liver. Light, immunohistochemical, and electron microscopic studies. , 1984, Gastroenterology.
[218] T. Billiar,et al. Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. , 1991, The American journal of physiology.
[219] J. Bremer. Carnitine--metabolism and functions. , 1983, Physiological reviews.
[220] A. Yasuhara,et al. Serum and urinary carnitine and organic acids in reye syndrome and Reye-like syndrome , 1986, Brain and Development.
[221] C. Shearman,et al. DNA replication by a membrane-DNA complex from rat liver mitochondria. , 1977, Archives of biochemistry and biophysics.
[222] T Hashimoto,et al. Novel fatty acid beta-oxidation enzymes in rat liver mitochondria. I. Purification and properties of very-long-chain acyl-coenzyme A dehydrogenase. , 1992, The Journal of biological chemistry.
[223] M. Suematsu,et al. Nitric oxide mediates Kupffer cell-induced reduction of mitochondrial energization in hepatoma cells: a comparison with oxidative burst. , 1993, Cancer research.
[224] Zhifang,et al. Molecular characterization of inherited medium-chain acyl-CoA dehydrogenase deficiency. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[225] B. Ames,et al. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[226] J. Enríquez,et al. Specific increase of a mitochondrial RNA transcript in chronic ethanol‐fed rats , 1992, FEBS letters.
[227] J. Mazat,et al. Uncoupling effects of local anesthetics on rat liver mitochondria , 1987, FEBS Letters.
[228] A. Hruszkewycz. Evidence for mitochondrial DNA damage by lipid peroxidation. , 1988, Biochemical and biophysical research communications.
[229] S. Hall. Reye's Syndrome and Aspirin: A Review , 1986, British journal of clinical practice. Supplement.
[230] D. Turnbull,et al. Impaired mitochondrial beta-oxidation in a patient with an abnormality of the respiratory chain. Studies in skeletal muscle mitochondria. , 1990, The Journal of clinical investigation.
[231] G. Mannaerts,et al. Mitochondrial and peroxisomal fatty acid oxidation in liver homogenates and isolated hepatocytes from control and clofibrate-treated rats. , 1979, The Journal of biological chemistry.
[232] A. Guillouzo,et al. Inhibition by perhexiline of oxidative phosphorylation and the β‐oxidation of fatty acids: Possible role in pseudoalcoholic liver lesions , 1994, Hepatology.
[233] J. Larrick,et al. IS REYE'S SYNDROME CAUSED BY AUGMENTED RELEASE OF TUMOUR NECROSIS FACTOR? , 1986, The Lancet.
[234] D. Wallace,et al. Diseases of the mitochondrial DNA. , 1992, Annual review of biochemistry.
[235] D. Pessayre,et al. Metabolic activation of the tricyclic antidepressant amineptine by human liver cytochrome P-450. , 1987, Biochemical pharmacology.
[236] K. Williams,et al. The stereoselective uptake of ibuprofen enantiomers into adipose tissue. , 1986, Biochemical pharmacology.
[237] C. Nathan,et al. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells , 1989, The Journal of experimental medicine.
[238] H. Schulz. Metabolism of 4-pentenoic acid and inhibition of thiolase by metabolites of 4-pentenoic acid. , 1983, Biochemistry.
[239] J. Ontko. Effects of ethanol on the metabolism of free fatty acids in isolated liver cells. , 1973, Journal of lipid research.
[240] M. Guzmán,et al. Ethanol feeding to rats reversibly decreases hepatic carnitine palmitoyltransferase activity and increases enzyme sensitivity to malonyl-CoA. , 1987, Biochemical and biophysical research communications.
[241] E. Zafrani,et al. Sodium Valproate in the Induction of Unusual Hepatotoxicity , 2007, Hepatology.
[242] D. Langer,et al. Valproic acid hepatic fatalities. , 1989, Neurology.
[243] M. Kelley,et al. Isolation and characterization of mitochondrial acyl-CoA: glycine N-acyltransferases from kidney. , 1993, Journal of biochemical toxicology.
[244] F. Plum,et al. Effect of acute ammonia intoxication on cerebral metabolism in rats with portacaval shunts. , 1977, The Journal of clinical investigation.
[245] P. Rustin,et al. Hepatic failure in disorders of oxidative phosphorylation with neonatal onset. , 1991, The Journal of pediatrics.
[246] R. Wenk,et al. Tetracycline-associated fatty liver of pregnancy, including possible pregnancy risk after chronic dermatologic use of tetracycline. , 1981, The Journal of reproductive medicine.
[247] M. Dalakas,et al. Mitochondrial myopathy caused by long-term zidovudine therapy. , 1990, The New England journal of medicine.
[248] B. Bacon,et al. Valproate use associated with persistent hyperammonemia and mitochondrial injury in a child with Down's syndrome. , 1992, Journal of Pediatric Gastroenterology and Nutrition - JPGN.
[249] P. Bartels,et al. Blood Lactate and Ketone Body Concentrations in Salicylate Intoxication , 1986, Human toxicology.
[250] R. Polin,et al. Metabolic and mitochondrial morphological changes that mimic Reye syndrome after endotoxin administration to rats , 1985, Infection and immunity.
[251] I. Paetzke-Brunner,et al. Serum Carnitine During Valproic Acid Therapy , 1986, Epilepsia.
[252] C. Stanley,et al. Genetic Deficiency of Medium-Chain Acyl Coenzyme A Dehydrogenase: Studies in Cultured Skin Fibroblasts and Peripheral Mononuclear Leukocytes , 1985, Pediatric Research.
[253] W. S. Thayer,et al. Molecular alterations in the respiratory chain of rat liver after chronic ethanol consumption. , 1981, The Journal of biological chemistry.
[254] D. Wallace. Mitochondrial genetics: a paradigm for aging and degenerative diseases? , 1992, Science.
[255] M. Beal,et al. Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age , 1992, Nature Genetics.
[256] G. Danan,et al. Pirprofen-induced fulminant hepatitis. , 1985, Gastroenterology.
[257] R. Day,et al. Chiral inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drugs--II. Racemization and hydrolysis of (R)- and (S)-ibuprofen-CoA thioesters. , 1991, Biochemical pharmacology.
[258] Tokumitsu Yukiko,et al. In vitro effects of nonsteroidal anti-inflammatory drugs on oxidative phosphorylation in rats liver mitochondria. , 1977, Biochemical pharmacology.
[259] S. Brusilow,et al. Inborn errors of metabolism in children referred with Reye's syndrome. A changing pattern. , 1988, JAMA.
[260] P. Meffin,et al. The stereospecific inhibition of endogenous triacylglycerol synthesis by fenoprofen in rat isolated adipocytes and hepatocytes. , 1990, Biochemical pharmacology.
[261] C. Hoppel,et al. Tetraphenylborate potentiates the respiratory inhibition by the dopaminergic neurotoxin MPP+ in both electron transport particles and intact mitochondria. , 1989, Biochemical and biophysical research communications.
[262] W. Hofmann,et al. Fatal Liver Failure in 16 Children with Valproate Therapy , 1988, Epilepsia.
[263] M. Heimberg,et al. Regulation by oestrogen of carnitine palmitoyltransferase in hepatic mitochondria. , 1986, The Biochemical journal.
[264] D. Turnbull,et al. Combined enzyme defect of mitochondrial fatty acid oxidation. , 1992, The Journal of clinical investigation.
[265] A. Boneh,et al. Effect of fatty acids and their acyl-CoA esters on protein kinase C activity in fibroblasts: possible implications in fatty acid oxidation defects. , 1994, Biochimica et biophysica acta.
[266] R. Victorino,et al. JAUNDICE ASSOCIATED WITH NAPROXEN , 1980, Postgraduate medical journal.
[267] P. Holland,et al. Biochemical effects of the hypoglycaemic compound pent-4-enoic acid and related non-hypoglycaemic fatty acids. Effects of the free acids and their carnitine esters on coenzyme A-dependent oxidations in rat liver mitochondria. , 1973, The Biochemical journal.
[268] B. H. Ch. Stricker,et al. Drug-induced Hepatic Injury , 1985 .
[269] D. Harris,et al. Studies of the kinetics of the isolated mitochondrial ATPase using dinitrophenol as a probe. , 1981, Biochimica et biophysica acta.
[270] D. Hegner,et al. The effects of some nutritive antibiotics on the respiration of rat liver mitochondria. , 1977, Biochemical pharmacology.
[271] P. Mortensen. INHIBITION OF FATTY ACID OXIDATION BY VALPROATE , 1980, The Lancet.
[272] K. Kassahun,et al. In vivo formation of the thiol conjugates of reactive metabolites of 4-ene VPA and its analog 4-pentenoic acid. , 1993, Drug metabolism and disposition: the biological fate of chemicals.
[273] W. Parker,et al. Salicylate-induced loose coupling: protonmotive force measurements. , 1985, Biochemical pharmacology.
[274] A. Feinstein,et al. New epidemiologic evidence confirming that bias does not explain the aspirin/Reye's syndrome association. , 1989, JAMA.
[275] M. Reitz,et al. Long-term inhibition of human T-lymphotropic virus type III/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2',3'-dideoxynucleosides in vitro. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[276] J. Weinberg,et al. Cytoprotective effects of glycine and glutathione against hypoxic injury to renal tubules. , 1987, The Journal of clinical investigation.
[277] K. Tanaka,et al. Selective inactivation of various acyl-CoA dehydrogenases by (methylenecyclopropyl)acetyl-CoA. , 1990, Biochimica et biophysica acta.
[278] T. Baillie,et al. Studies on the biotransformation in the perfused rat liver of 2-n-propyl-4-pentenoic acid, a metabolite of the antiepileptic drug valproic acid. Evidence for the formation of chemically reactive intermediates. , 1985, Drug metabolism and disposition: the biological fate of chemicals.
[279] H. Mitsuya,et al. Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[280] K. Ishak,et al. Valproate‐Induced Hepatic Injury: Analyses of 23 Fatal Cases , 2007, Hepatology.
[281] Broder,et al. Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[282] S. Sherlock. Acute fatty liver of pregnancy and the microvesicular fat diseases. , 1983, Gut.
[283] K. Ishak,et al. Acute fatty liver of pregnancy: A clinicopathologic study of 35 cases , 1985, Hepatology.
[284] G. Labbe,et al. Amiodarone inhibits the mitochondrial beta-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice. , 1990, The Journal of pharmacology and experimental therapeutics.
[285] E.Stewert Allen,et al. Hepatic toxicity of tetracycline in pregnancy. , 1966, American journal of obstetrics and gynecology.
[286] R. Ponzone,et al. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: the prevalent mutation G985 (K304E) is subject to a strong founder effect from northwestern Europe. , 1993, Human heredity.
[287] D. Nathans,et al. Inhibition of aminoacyl-sRNA binding to ribosomes by tetracycline , 1965 .
[288] L. Goodman,et al. The Pharmacological Basis of Therapeutics , 1941 .
[289] M. Guzmán,et al. Alterations in the regulatory properties of hepatic fatty acid oxidation and carnitine palmitoyltransferase I activity after ethanol feeding and withdrawal. , 1990, Alcoholism, clinical and experimental research.
[290] G. Bras,et al. Acute toxic hypoglycaemia occurring in the vomiting sickness of Jamaica; morbid anatomical aspects. , 1955, The West Indian medical journal.
[291] M. J. Coon,et al. Resolution of the cytochrome P-450-containing omega-hydroxylation system of liver microsomes into three components. , 1969, The Journal of biological chemistry.
[292] E. Smuckler,et al. Lipid content in the liver of fatty metamorphosis of pregnancy. , 1975, The American journal of pathology.
[293] J. Adamson,et al. Pathology of Labour and Puerperium: FATAL LIVER DISEASE AFTER INTRAVENOUS ADMINISTRATION OF TETRACYCLINE IN HIGH DOSAGE , 1963 .
[294] L. Hue,et al. Protection of rats by clofibrate against the hypoglycaemic and toxic effects of hypoglycin and pent-4-enoate. An ultrastructural and biochemical study. , 1985, Biochemical Journal.
[295] C. Vianey‐Saban,et al. Very long chain acyl-CoA dehydrogenase deficiency: identification of a new inborn error of mitochondrial fatty acid oxidation in fibroblasts. , 1993, Biochimica et biophysica acta.
[296] R. Coleman,et al. Sodium valproate inhibits the movement of secretory vesicles in rat hepatocytes. , 1987, The Biochemical journal.
[297] A. Munnich,et al. Fatal neonatal liver failure and mitochondrial cytopathy (oxidative phosphorylation deficiency): A light and electron microscopic study of the liver , 1993, Hepatology.
[298] J. Bravo,et al. Fatty liver and pleural effusion with ibuprofen therapy. , 1977, Annals of internal medicine.
[299] S. Schenker,et al. Effect of tetracycline on the metabolism of [1-14C]oleate by the liver. , 1979, Biochemical pharmacology.
[300] M. Holtrop,et al. Different effects of oxytetracycline and doxycycline on mitochondrial protein synthesis in rat liver after long-term treatment. , 1987, Biochemical pharmacology.
[301] H. Rouach,et al. Implication of free radical mechanisms in ethanol-induced cellular injury. , 1992, Free radical biology & medicine.
[302] M. Marletta,et al. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[303] E. Kempner,et al. Bile acid: CoASH ligases from guinea pig and porcine liver microsomes. Purification and characterization. , 1987, The Journal of biological chemistry.
[304] Sangkot Marzuki,et al. MITOCHONDRIAL DNA MUTATIONS AS AN IMPORTANT CONTRIBUTOR TO AGEING AND DEGENERATIVE DISEASES , 1989, The Lancet.
[305] C. F. Baxter,et al. Regulation of fatty acid β-oxidation in rat heart mitochondria , 1991 .
[306] T Hashimoto,et al. Novel fatty acid beta-oxidation enzymes in rat liver mitochondria. II. Purification and properties of enoyl-coenzyme A (CoA) hydratase/3-hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase trifunctional protein. , 1992, The Journal of biological chemistry.
[307] W. Schubert,et al. Mitochondrial ultrastructure in Reye's syndrome (encephalopathy and fatty degeneration of the viscera). , 1971, The New England journal of medicine.
[308] J. Neaton,et al. A comparative trial of didanosine or zalcitabine after treatment with zidovudine in patients with human immunodeficiency virus infection. The Terry Beirn Community Programs for Clinical Research on AIDS. , 1994, The New England journal of medicine.
[309] K. Knights,et al. The effects of ibuprofen enantiomers on hepatocyte intermediary metabolism and mitochondrial respiration. , 1992, Biochemical pharmacology.
[310] D. Turnbull,et al. The effects of valproate on intermediary metabolism in isolated rat hepatocytes and intact rats. , 1983, Biochemical pharmacology.
[311] D. Billington,et al. Mechanisms of the metabolic disturbances caused by hypoglycin and by pent-4-enoic acid. In vivo studies. , 1978, Biochemical pharmacology.
[312] C. Chin,et al. Studies on the inhibition of mitochondrial DNA replication by 3'-azido-3'-deoxythymidine and other dideoxynucleoside analogs which inhibit HIV-1 replication. , 1989, Biochemical pharmacology.
[313] R. Harris,et al. Inhibition of metabolic processes by coenzyme-A-sequestering aromatic acids. Prevention by para-chloro- and para-nitrobenzoic acids. , 1987, Biochemical pharmacology.
[314] R. Hauhart,et al. Reversal of the Adverse Chronic Effects of the Unsaturated Derivative of Valproic Acid—2-n-Propyl-4-Pentenoic Acid—on Ketogenesis and Liver Coenzyme A Metabolism by a Single Injection of Pantothenate, Carnitine, and Acetylcysteine in Developing Mice , 1993, Pediatric Research.
[315] E. Brass,et al. Inhibition of oxidative metabolism by propionic acid and its reversal by carnitine in isolated rat hepatocytes. , 1986, The Biochemical journal.
[316] R. Gräbner. Influence of cationic amphiphilic drugs on the phosphatidylcholine hydrolysis by phospholipase A2. , 1987, Biochemical pharmacology.
[317] C. Marescaux,et al. The renal origin of sodium valproate‐induced hyperammonemia in fasting humans , 1983, Neurology.
[318] M A Fischl,et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. , 1987, The New England journal of medicine.
[319] N. Turro,et al. Increased NADPH- and NADH-dependent production of superoxide and hydroxyl radical by microsomes after chronic ethanol treatment. , 1993, Archives of biochemistry and biophysics.
[320] E. Richardson,et al. Fatal reye‐like syndrome associated with valproic acid , 1980, Annals of neurology.
[321] L. Sultatos. Effects of acute ethanol administration on the hepatic xanthine dehydrogenase/oxidase system in the rat. , 1988, The Journal of pharmacology and experimental therapeutics.
[322] S. Ledoux,et al. Repair of oxidative damage within the mitochondrial DNA of RINr 38 cells. , 1993, The Journal of biological chemistry.
[323] K. Farrell,et al. The effect of aspirin on valproic acid metabolism , 1986, Clinical pharmacology and therapeutics.
[324] V. Sborov,et al. Fatty liver following aureomycin and terramycin therapy in chronic hepatic disease. , 1951, Gastroenterology.
[325] H. Noller,et al. Molecular basis of tetracycline action: identification of analogs whose primary target is not the bacterial ribosome , 1991, Antimicrobial Agents and Chemotherapy.
[326] I. Damjanov,et al. Tetracycline Toxicity in A Nonpregnant Woman , 1968 .
[327] D. Jelliffe,et al. Acute Toxic Hypoglycaemia in the Vomiting Sickness of Jamaica , 1954, British medical journal.
[328] T. Ozawa,et al. Massive conversion of guanosine to 8-hydroxy-guanosine in mouse liver mitochondrial DNA by administration of azidothymidine. , 1991, Biochemical and biophysical research communications.
[329] S. Krähenbühl,et al. Toxicity of bile acids on the electron transport chain of isolated rat liver mitochondria , 1994, Hepatology.
[330] K. Feingold,et al. Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo. , 1987, The Journal of clinical investigation.
[331] J. Caldwell,et al. The metabolic chiral inversion and dispositional enantioselectivity of the 2-arylpropionic acids and their biological consequences. , 1988, Biochemical pharmacology.
[332] D. Pessayre,et al. Decreased mitochondrial oxidation of fatty acids in pregnant mice: Possible relevance to development of acute fatty liver of pregnancy , 1993, Hepatology.
[333] W. Coleman,et al. Effects of chronic ethanol consumption on the synthesis of polypeptides encoded by the hepatic mitochondrial genome. , 1990, Biochimica et biophysica acta.
[334] R. Okita. Effect of Acetylsalicylic Acid on Fatty Acid ω-Hydroxylation in Rat Liver , 1986, Pediatric Research.
[335] A. Luder,et al. Inactivation of beef brain alpha-ketoglutarate dehydrogenase complex by valproic acid and valproic acid metabolites. Possible mechanism of anticonvulsant and toxic actions. , 1990, The Journal of clinical investigation.
[336] V. Maddaiah,et al. Effects of Ammonium Chloride, Salicylate, and Carnitine on Palmitic Acid Oxidation in Rat Liver Slices , 1989, Pediatric Research.
[337] N. Takeyama,et al. Altered hepatic fatty acid metabolism in endotoxicosis: effect of L-carnitine on survival. , 1989, The American journal of physiology.
[338] W. Kean,et al. Chirality in antirheumatic drugs , 1991, The Lancet.
[339] H. Sherratt. Hypoglycin and related hypoglycaemic compounds. , 1969, British medical bulletin.
[340] B. Wilcken,et al. Recurrent acute fatty liver of pregnancy associated with a fatty-acid oxidation defect in the offspring. , 1991, Gastroenterology.
[341] H. Sherratt. Hypoglycin, the famous toxin of the unripe Jamaican ackee fruit , 1986 .
[342] R. Peters,et al. Giant mitochondria in the alcoholic liver diseases--their identification, frequency and pathologic significance. , 2008, Liver.
[343] S. Dimauro,et al. A direct repeat is a hotspot for large-scale deletion of human mitochondrial DNA. , 1989, Science.
[344] N. Kaplowitz,et al. Hepatic mitochondrial glutathione depletion and progression of experimental alcoholic liver disease in rats , 1992, Hepatology.
[345] T. Ozawa,et al. Age-associated oxygen damage and mutations in mitochondrial DNA in human hearts. , 1992, Biochemical and biophysical research communications.
[346] L. Horowitz,et al. Amiodarone for control of sustained ventricular tachyarrhythmia: clinical and electrophysiologic effects in 51 patients. , 1982, The American journal of cardiology.
[347] Yohnosuke Kobayashi,et al. Hepatotoxicity in Rat Following Administration of Valproic Acid: Effect of L‐Carnitine Supplementation , 1987, Epilepsia.
[348] G. Granneman,et al. Aspects of the metabolism of valproic acid. , 1984, Xenobiotica; the fate of foreign compounds in biological systems.
[349] G. Labbe,et al. Stereoselective and nonstereoselective effects of ibuprofen enantiomers on mitochondrial beta-oxidation of fatty acids. , 1990, The Journal of pharmacology and experimental therapeutics.
[350] William,et al. Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria. , 1992, The Journal of clinical investigation.
[351] R. Hernández-Muñoz,et al. Impaired oxygen utilization. A new mechanism for the hepatotoxicity of ethanol in sub-human primates. , 1989, The Journal of clinical investigation.
[352] T. Baillie,et al. Cytochrome P-450-mediated dehydrogenation of 2-n-propyl-2(E)-pentenoic acid, a pharmacologically-active metabolite of valproic acid, in rat liver microsomal preparations. , 1993, Drug metabolism and disposition: the biological fate of chemicals.
[353] L. Wojtczak,et al. Effect of fatty acids on energy coupling processes in mitochondria. , 1993, Biochimica et biophysica acta.
[354] M. Suematsu,et al. Nitric oxide mediates lipopolysaccharide‐induced alteration of mitochondrial function in cultured hepatocytes and isolated perfused liver , 1993, Hepatology.
[355] E. Saint,et al. A NOTE ON FATTY CHANGE IN THE LIVER COMPLICATING AUREOMYCIN THERAPY , 1953, The Medical journal of Australia.
[356] F. Iber. Alcohol and the gastrointestinal tract. , 1971, Gastroenterology.
[357] R. Ramsay,et al. Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, by mitochondria. , 1986, The Journal of biological chemistry.
[358] A. Beavis. On the inhibition of the mitochondrial inner membrane anion uniporter by cationic amphiphiles and other drugs. , 1989, The Journal of biological chemistry.
[359] D. Williamson,et al. THE EFFECTS OF CYCLOPROPANE DERIVATIVES ON KETONE-BODY METABOLISM IN VIVO. , 1965, The Biochemical journal.
[360] S. Krähenbühl,et al. Mechanisms of impaired hepatic fatty acid metabolism in rats with long‐term bile duct ligation , 1994, Hepatology.
[361] C. E. Day,et al. Effects of tetracycline on ultrastructure and lipoprotein secretion in the rat hepatocyte , 1974 .
[362] D. Norwood,et al. Mitochondrial metabolism of valproic acid. , 1991, Biochemistry.
[363] N. Kaplowitz,et al. Effect of chronic ethanol feeding on rat hepatocytic glutathione. Compartmentation, efflux, and response to incubation with ethanol. , 1987, The Journal of clinical investigation.
[364] J. Ritter,et al. Once-daily administration of 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Results of a Phase I trial. , 1990, The New England journal of medicine.
[365] F. Van hoof,et al. In vitro effects of valproate and valproate metabolites on mitochondrial oxidations. Relevance of CoA sequestration to the observed inhibitions. , 1992, Biochemical pharmacology.
[366] T. Baillie,et al. Studies on the beta-oxidation of valproic acid in rat liver mitochondrial preparations. , 1991, Drug metabolism and disposition: the biological fate of chemicals.
[367] C. Marescaux,et al. Succinate transport inhibition by valproate in rat renal mitochondria. , 1989, European journal of pharmacology.
[368] G. Grimber,et al. Action of the antiepileptic drug, valproic acid, on fatty acid oxidation in isolated rat hepatocytes. , 1983, Biochemical and biophysical research communications.
[369] C. Soler-Argilaga,et al. Effects of ethynyloestradiol on the metabolism of [1-14C]oleate by perfused livers and hepatocytes from female rats. , 1979, The Biochemical journal.
[370] C. Cunningham,et al. Control of state 3 respiration in liver mitochondria from rats subjected to chronic ethanol consumption. , 1987, Biochimica et biophysica acta.
[371] W. Schubert,et al. SERUM SALICYLATE CONCENTRATIONS IN REYE'S DISEASE A Study of 130 Biopsy-proven Cases , 1982, The Lancet.
[372] R. Ekholm,et al. Ultrastructure of the rat exocrine pancreas after long term intake of ethanol. , 1970, Gastroenterology.
[373] M Bichara,et al. Perhexiline maleate-induced cirrhosis. , 1979, Gastroenterology.
[374] H. Petit,et al. Unusual electronmicroscopic changes in valproate-associated liver failure , 1993, The Lancet.
[375] G. Dubin,et al. Zidovudine-induced hepatotoxicity. , 1989, Annals of internal medicine.
[376] W. S. Thayer,et al. Immunochemical evidence for an inactive form of cytochrome oxidase in mitochondrial membranes of ethanol-fed rats. , 1986, Biochimica et biophysica acta.
[377] M. Guzmán,et al. Regulation of fatty acid oxidation in mammalian liver. , 1993, Biochimica et biophysica acta.
[378] D. Turnbull,et al. Acute fatty liver of pregnancy and long‐chain 3‐hydroxyacyl–coenzyme A dehydrogenase deficiency , 1994, Hepatology.
[379] P. Meffin,et al. Enantiospecific formation of fenoprofen coenzyme A thioester in vitro. , 1988, Biochemical Pharmacology.
[380] A R Temple,et al. Acute and chronic effects of aspirin toxicity and their treatment. , 1981, Archives of internal medicine.
[381] J. Drapier,et al. Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells. , 1988, Journal of immunology.
[382] G. Labbe,et al. Inhibition of mitochondrial beta-oxidation of fatty acids by pirprofen. Role in microvesicular steatosis due to this nonsteroidal anti-inflammatory drug. , 1987, The Journal of pharmacology and experimental therapeutics.
[383] R. Ramsay,et al. Enhancement by tetraphenylboron of the interaction of the 1-methyl-4-phenylpyridinium ion (MPP+) with mitochondria. , 1989, Biochemical and biophysical research communications.
[384] T. Tracy,et al. Metabolic inversion of (R)-ibuprofen. Formation of ibuprofenyl-coenzyme A. , 1993, Drug metabolism and disposition: the biological fate of chemicals.
[385] G. Singh,et al. Mitochondrial DNA damage by anticancer agents. , 1992, Pharmacology & therapeutics.
[386] C. Lieber. Biochemical and molecular basis of alcohol-induced injury to liver and other tissues. , 1988, The New England journal of medicine.
[387] M. Thaler,et al. Reye's syndrome due to a novel protein-tolerant variant of ornithine-transcarbamylase deficiency. , 1974, Lancet.
[388] Leon Schiff,et al. Diseases of the liver , 1975 .
[389] H. Kasai,et al. Misreading of DNA templates containing 8-hydroxydeoxyguanosine at the modified base and at adjacent residues , 1987, Nature.
[390] A. Cederbaum. Introduction: role of lipid peroxidation and oxidative stress in alcohol toxicity , 1989 .
[391] R. Bowsher,et al. Fialuridine accumulates in DNA of dogs, monkeys, and rats following long-term oral administration. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[392] A. E. Senior,et al. A comparison of the effects on blood glucose and ketone‐body levels, and of the toxicities, of pent‐4‐enoic acid and four simple fatty acids , 1969, The Journal of pharmacy and pharmacology.
[393] G. Vawter,et al. Tetracycline hepatotoxicity in the differential diagnosis of postoperative jaundice. , 1974, The Journal of pediatrics.
[394] H. Zimmerman. Effects of aspirin and acetaminophen on the liver. , 1981, Archives of internal medicine.
[395] R. E. Beyer. An analysis of the role of coenzyme Q in free radical generation and as an antioxidant. , 1992, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[396] K. Bove,et al. Transiently reduced activity of carbamyl phosphate synthetase and ornithine transcarbamylase in liver of children with Reye's syndrome. , 1976, The New England journal of medicine.
[397] T. Baillie,et al. Evidence of multiple forms of rat liver microsomal coenzyme A ligase catalysing the formation of 2-arylpropionyl-coenzyme A thioesters. , 1992, Biochemical pharmacology.
[398] W. Schubert,et al. Reye's syndrome: Current concepts , 1987, Hepatology.
[399] C. Stanley. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency. , 1987, Advances in pediatrics.
[400] G. Addison,et al. Sodium Valproate and Acute Hepatic Failure , 1980, Developmental medicine and child neurology.
[401] I. Björkhem. Omega-oxidation of stearic acid in the normal, starved and diabetic rat liver. , 1973, European journal of biochemistry.
[402] J. Lancaster,et al. Inhibition of target cell mitochondrial electron transfer by tumor necrosis factor , 1989, FEBS letters.
[403] S. Krähenbühl. Alterations in mitochondrial function and morphology in chronic liver disease: pathogenesis and potential for therapeutic intervention. , 1993, Pharmacology & therapeutics.
[404] R. Estruch,et al. The effects of alcoholism on skeletal and cardiac muscle. , 1989, The New England journal of medicine.
[405] J. Vamecq,et al. The inhibition by valproic acid of the mitochondrial oxidation of monocarboxylic and omega-hydroxymonocarboxylic acids: possible implications for the metabolism of gamma-aminobutyric acid. , 1987, Journal of biochemistry.
[406] J. Lancaster,et al. EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[407] B. Combes,et al. TETRACYCLINE TOXICITY IN PREGNANCY. LIVER AND PANCREATIC DYSFUNCTION. , 1964, JAMA.
[408] S. Moncada,et al. The L-arginine-nitric oxide pathway. , 1993, The New England journal of medicine.
[409] R. Reitz,et al. The effects of ethanol ingestion on lipid metabolism. , 1979, Progress in lipid research.
[410] C. Marescaux,et al. Effects of sodium valproate on mitochondrial membranes: electron paramagnetic resonance and transmembrane protein movement studies. , 1986, Molecular pharmacology.
[411] R. Lüllmann-Rauch,et al. Drug-induced phospholipidoses. II. Tissue distribution of the amphiphilic drug chlorphentermine. , 1975, CRC critical reviews in toxicology.
[412] C. H. Chen,et al. Delayed cytotoxicity and selective loss of mitochondrial DNA in cells treated with the anti-human immunodeficiency virus compound 2',3'-dideoxycytidine. , 1989, The Journal of biological chemistry.
[413] H. Terada,et al. The interaction of highly active uncouplers with mitochondria. , 1981, Biochimica et biophysica acta.
[414] A. Rötig,et al. Hepatic mitochondrial DNA deletion in alcoholics: association with microvesicular steatosis. , 1995, Gastroenterology.
[415] D. Dhumeaux,et al. Amiodarone‐induced hepatic phospholipidosis: A morphological alteration independent of pseudoalcoholic liver disease , 1988, Hepatology.
[416] M. E. Charness,et al. Ethanol and the nervous system. , 1989, The New England journal of medicine.
[417] N. Sussman,et al. A direct hepatotoxic effect of valproic acid. , 1979, JAMA.
[418] R. Polin,et al. Hepatic metabolic alterations in rats treated with low-dose endotoxin and aspirin: an animal model of Reye's syndrome. , 1989, Metabolism: clinical and experimental.
[419] A. Baruzzi,et al. Carnitine Disposition Before and During Valproate Therapy in Patients with Epilepsy , 1993, Epilepsia.
[420] F. Van hoof,et al. Influence of chronic administration of valproate on ultrastructure and enzyme content of peroxisomes in rat liver and kidney. Oxidation of valproate by liver peroxisomes. , 1991, Biochemical pharmacology.
[421] B. Peters,et al. Mitochondrial myopathy associated with chronic zidovudine therapy in AIDS. , 1993, The Quarterly journal of medicine.
[422] B. Ludwig,et al. A threshold membrane potential accounts for controversial effects of fatty acids on mitochondrial oxidative phosphorylation , 1993, FEBS letters.
[423] W. Hickey,et al. Early childhood hepatocerebral degeneration misdiagnosed as valproate hepatotoxicity , 1992, Annals of neurology.
[424] B. Wilder,et al. Valproic acid. Review of a new antiepileptic drug. , 1979, Archives of neurology.
[425] G. Delong,et al. Urea-cycle enzyme deficiencies and an increased nitrogen load producing hyperammonemia in Reye's syndrome. , 1976, The New England journal of medicine.
[426] J. Stamler,et al. Biochemistry of nitric oxide and its redox-activated forms. , 1992, Science.
[427] G. Granneman,et al. The Hepatotoxicity of Valproic Acid and Its Metabolites in Rats. II. Intermediary and Valproic Acid Metabolism , 1984, Hepatology.
[428] K. Carpenter,et al. Human liver long-chain 3-hydroxyacyl-coenzyme A dehydrogenase is a multifunctional membrane-bound beta-oxidation enzyme of mitochondria. , 1992, Biochemical and biophysical research communications.
[429] G. Gores,et al. Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium. , 1993, The Journal of clinical investigation.
[430] M L Walsh,et al. Localization of mitochondria in living cells with rhodamine 123. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[431] M A Fischl,et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. , 1987, The New England journal of medicine.
[432] J. Fléjou,et al. La stéatose spongiocytaire alcoolique: étude de trois cas. , 1987 .
[433] M. Beaugrand,et al. Hépatites au maléate de perhexiline (Pexid). Evoluant vers la cirrhose malgré l'arrêt du traitement (2 cas). , 1977 .
[434] G. Labbe,et al. Inhibition of the mitochondrial oxidation of fatty acids by tetracycline in mice and in man: Possible role in microvesicular steatosis induced by this antibiotic , 1988, Hepatology.
[435] H. Osmundsen,et al. A Novel mechanism for inhibition of β‐oxidation by methylenecyclopropylacetyl‐CoA, a metabolite of hypoglycin , 1975, FEBS letters.
[436] T. Bohan,et al. Valproylcarnitine: a novel drug metabolite identified by fast atom bombardment and thermospray liquid chromatography-mass spectrometry. , 1985, Clinica chimica acta; international journal of clinical chemistry.
[437] P. Brooks,et al. Clinical Pharmacokinetics of the Salicylates , 1985, Clinical pharmacokinetics.
[438] R. Butterworth,et al. Effects of congenital hyperammonemia on the cerebral and hepatic levels of the intermediates of energy metabolism in spf mice. , 1992, Biochemical and biophysical research communications.
[439] P. Killenberg,et al. Evidence for a medium-chain fatty acid: coenzyme A ligase (adenosine monophosphate) that activates salicylate. , 1971, Molecular pharmacology.
[440] P. Blanc,et al. Tianeptine--an instance of drug-induced hepatotoxicity predicted by prospective experimental studies. , 1994, Journal of hepatology.
[441] M. Whitehouse,et al. About some common biochemical and pharmacological properties of bile salts and non steroidal anti-inflammatory drugs. , 1978, Archives internationales de physiologie et de biochimie.
[442] J. Capron,et al. Hépatite cholestatique à l'amineptine. A propos de 5 observations. , 1980 .
[443] H. Mitsuya,et al. Clinical pharmacology of 3'-azido-2',3'-dideoxythymidine (zidovudine) and related dideoxynucleosides. , 1989, The New England journal of medicine.
[444] P. Meffin,et al. The stereospecific incorporation of fenoprofen into rat hepatocyte and adipocyte triacylglycerols. , 1988, Biochemical pharmacology.
[445] J. Brand,et al. A probable defect in the β-oxidation of lipids in rats fed alcohol for 6 months , 1991 .
[446] D. W. Schulz,et al. Chronic valproate administration produces hepatic dysfunction and may delay brain maturation in infant mice , 1981, Neurology.
[447] R. Salem,et al. Dequalinium, a topical antimicrobial agent, displays anticarcinoma activity based on selective mitochondrial accumulation. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[448] T. Baillie,et al. Inhibition of medium-chain fatty acid beta-oxidation in vitro by valproic acid and its unsaturated metabolite, 2-n-propyl-4-pentenoic acid. , 1985, Biochemical and biophysical research communications.
[449] R. Tucker,et al. POSSIBLE PATHOGENIC ROLE OF ENDOTOXIN IN REYE'S SYNDROME , 1975, The Lancet.
[450] T. Browne,et al. Drug therapy: Valproic acid. , 1980, The New England journal of medicine.
[451] D. Pessayre,et al. Inhibition by salicylic acid of the activation and thus oxidation of long chain fatty acids. Possible role in the development of Reye's syndrome. , 1991, The Journal of pharmacology and experimental therapeutics.
[452] T. Billiar,et al. Tumor necrosis factor alpha inhibits hepatocyte mitochondrial respiration. , 1992, Annals of surgery.
[453] R. Allen,et al. Valproic acid therapy in childhood epilepsy. , 1980, JAMA.
[454] S. Moncada,et al. Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.
[455] J. Hoofnagle,et al. Reye's syndrome-like illness in a patient receiving amiodarone. , 1988, The American journal of gastroenterology.
[456] H. Zimmerman,et al. Hepatotoxicity: The adverse effects of drugs and other chemicals on the liver , 1978 .
[457] B. P. Yu,et al. Cellular defenses against damage from reactive oxygen species. , 1994, Physiological reviews.
[458] C. Balabaud,et al. Fatal neonatal liver failure and mitochondrial cytopathy: an observation with antenatal ascites. , 1992, Gastroenterology.
[459] T. Billiar,et al. Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis. , 1990, Annals of surgery.
[460] T. Baillie,et al. Biotransformation and pharmacokinetics in the rhesus monkey of 2-n-propyl-4-pentenoic acid, a toxic metabolite of valproic acid. , 1986, Drug metabolism and disposition: the biological fate of chemicals.
[461] J. Kondrup,et al. The effect of ethanol on the beta-oxidation of fatty acids. , 1986, Alcoholism, clinical and experimental research.
[462] E. Brass,et al. Fuel homeostasis and carnitine metabolism in rats with secondary biliary cirrhosis , 1991, Hepatology.
[463] J. Hiltunen,et al. Regulation of palmitoylcarnitine oxidation in isolated rat liver mitochondria. Role of the redox state of NAD(H). , 1986, Biochimica et biophysica acta.
[464] M. Guzmán,et al. Effects of ethanol feeding on the activity and regulation of hepatic carnitine palmitoyltransferase I. , 1988, Archives of biochemistry and biophysics.
[465] J. Spivak,et al. Suppression of hematopoietic-progenitor-cell proliferation by ethanol and acetaldehyde. , 1982, The New England journal of medicine.
[466] R. Scully,et al. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. , 1976, The New England journal of medicine.
[467] M. Strolin Benedetti,et al. [Hepatotoxicity of amineptin and inhibition of beta-oxidation of fatty acids]. , 1984, Therapie.